Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison

Journal of Viral Hepatitis
Lise LaffertySToP-C Study Group

Abstract

Hepatitis C virus (HCV) infection is a major public health concern. Globally, 15% of those incarcerated are HCV-antibody positive (anti-HCV). Even where HCV treatment is available within prisons, treatment uptake has remained low. This qualitative study was conducted to understand the barriers and facilitators for the delivery of HCV treatment in prisons from the perspectives of prisoners. This is important to inform health messaging for HCV treatment within correctional institutions. Thirty-two prisoners (including eight women) with a history of injecting drug use participated in this qualitative study. Participants were equally recruited across four correctional centres (n = 8 per site). Overall, 16 participants (50%) had chronic HCV at their most recent test, and two participants were awaiting test results at time of interview. Structural (eg proximity of health clinic) and patient-level (routine and motivation) factors were viewed as facilitators of HCV treatment within the prison setting. Structural (eg risk of reinfection) and social (eg lack of confidentiality and lack of social support) factors were perceived as barriers to prison-based HCV care and treatment. In conclusion, to increase HCV treatment uptake, prison-base...Continue Reading

References

Jan 11, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Christopher E McGowan, Michael W Fried
Jul 3, 2013·Nature Reviews. Gastroenterology & Hepatology·Behzad HajarizadehGregory J Dore
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carla TreloarMarkus Backmund
Mar 20, 2014·The Medical Journal of Australia·Joanne M ReekieTony G Butler
Mar 29, 2014·Journal of Public Health Management and Practice : JPHMP·Paul Campbell Erwin, C William Keck
Apr 22, 2015·Emerging Infectious Diseases·Neil Arvin BretañaUNKNOWN HITS-p investigators
Mar 5, 2016·International Journal of Prisoner Health·Michael Mokhlis MinaAndrew Lloyd
Jul 19, 2016·Lancet·Leonard S RubensteinChris Beyrer
Sep 13, 2016·Health & Justice·Lise LaffertyGeorgina M Chambers
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory HCV Collaborators
Dec 16, 2017·Drug and Alcohol Dependence·Lise LaffertyCarla Treloar

❮ Previous
Next ❯

Citations

Jun 4, 2020·Journal of Viral Hepatitis·Kathryn JackWilliam Lucien Irving
May 19, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather ValerioJason Grebely
May 1, 2020·Frontiers in Psychiatry·Abby RowlandsSophia Vinogradov
May 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah Kattakuzhy, Elana Rosenthal
Nov 6, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ani KardashianJennifer C Price
Nov 8, 2020·The International Journal on Drug Policy·Kathleen M WardOluwaseun Falade-Nwulia
Feb 8, 2021·Journal of Viral Hepatitis·Laura KrekulovaLee W Riley
Apr 16, 2021·The Lancet. Gastroenterology & Hepatology·Matthew J AkiyamaUNKNOWN International Network on Health and Hepatitis in Substance Users–Prisons Network
May 10, 2021·The Lancet. Gastroenterology & Hepatology·Behzad HajarizadehUNKNOWN SToP-C study group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.